Comparison of the total and regional scores between the patients with deterioration and stable patients
| 123I BMIPP | Thallium-201 | ||||||
|---|---|---|---|---|---|---|---|
| Deteriorated patients (n = 11) | Stable patients (n = 21) | Deteriorated patients (n = 11) | Stable patients (n = 21) | ||||
| Total region | 20.0 (7.2) | 14.5 (8.1) | 17.6 (5.7) | 15.1 (7.6) | |||
| Anterior region | 4.5 (3.2) | 3.3 (3.1) | 3.8 (3.3) | 3.6 (3.2) | |||
| Lateral region | 2.3 (3.4) | 1.8 (3.0) | 1.8 (2.6) | 1.6 (3.0) | |||
| Inferior region | 7.2 (1.5) | 6.2 (3.5) | 6.0 (2.5) | 6.4 (3.2) | |||
| Septal region | 5.2 (3.5) | 2.3 (2.5)4-150 | 4.3 (3.7) | 2.8 (2.6) | |||
| Apical region | 2.0 (1.9) | 1.4 (1.5) | 1.4 (2.0) | 1.6 (1.7) | |||
Data are mean (SD).
↵4-150 p < 0.01; unpaired t test.
BMIPP, β-methyl-iodo-phenyl pentadecanoic acid.